Correction: Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens

Authors

Publication Details

Journal
Frontiers in Microbiology
Published
2026-02-13
DOI
https://doi.org/10.3389/fmicb.2026.1793977
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens

Frontiers Production Office
Frontiers in Microbiology
Clostridium difficile and Clostridium perfringens research
article

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens

Frontiers Production Office
article en

Abstract

No abstract available for this paper.
Frontiers in MicrobiologyVol. 17
Openalex Percentile: Top 56%
Clostridium difficile and Clostridium perfringens research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens — Frontiers Production Office · Frontiers in Microbiology (2026) | TGRS Research Map | TGRS